| |
Objective is to achieve the goal to serve a Single Stop solution provider for Biotechnology and Pharmaceutical sectors research and development.
To accomplish this we use innovative technology in microbiology, molecular biology, industrial biotechnology and bioinformatics and have established a complete and highly productive platform which supports the advance of our developments.
Our Company’s unique business model provides significant cost savings to our customers by offering bulk sera as well as bulk amounts of recombinant proteins at high purity. Our experienced biotech staff understands the need to deliver high quality products on time as well as the need to ensure excellent quality standards. In addition, our diverse staff has extensive knowledge of conducting business seamlessly for our national and international customers.
| Dr. Michael Ryan PhD, was the Prominent Group Scientist with more than 25 years of overseas industrial experience with the major countries like USA, CANADA, United Kingdom, Singapore, out of which 13 years of his experience focused on research and development with the biological and life science sector. His areas of specialization are Industrial Microbiology, Molecular biology and Immunology. |
| Dr. Seema Kulkarni PhD, is the one among the entrepreneur and scientist with 25 years of experience in developing cell biology and molecular biology marker and assay. She had guided close to 10 research scholars in various discipline like Molecular Genetics, Cell Biology, and Molecular biology. She is more expertise in Molecular Phylogentics studies in population between various Animals and Plant species. |
| Dr. Martin Fernando PhD, was the one among the Group Scientist with more than 18 years of Experience out of which 8 years of his experience focused on Pharmaceutical Drug discovery and Bioinformatics. He is the life member International Society for computational Biology. He is also member of International Bioinformatics Support Network. He is also a visiting Professor and Guest lecturer in various leading University (USA, INDIA, SOUTH AFRICA). |
| Dr. Uma Maheshwar Rao PhD, is the one among the entrepreneur and scientist with 15 years of experience and supported for long term overseas contract research and consultancy in Molecular biology, Microbiology and Industrial Biotechnology (Enzyme Engineering).He has close to 8 years of experience in implementing the pilot project and technology transfer of various products for various esteemed Biotechnology organisation and pharmaceutical industry. |
Michael Ryan - Biotechnology a Milestone
Biotechnology uses living cells and materials produced by cells to create pharmaceutical, diagnostic, agricultural, environmental, and other products to benefit society. The science of biotechnology is also used to alter genetic information in animals and plants to improve them in some way that benefits people. Because biotechnology essentially uses the basic ingredients of life to make new products, it is both a cutting-edge technology and an applied science. Analysts have predicted that biotechnology will be one of the most important applied sciences of the 21st century.
Proponents of this method of producing copies of organisms have suggested that cloning technology might be used to improve agricultural stock and to regenerate endangered species. These ideas have had their detractors, however, as critics have noted the potential dangers of narrowing a species’ gene pool. The July, 1996, birth in Scotland of Dolly, a sheep cloned and raised to adulthood, demonstrated that the cloning of animals had left the realm of science fiction and become a matter of scientific fact.
Seema Kulkarni - Advance Technology in Biotechnology
In practice, recombinant DNA methodology is complex, but in concept, it is fairly easy to comprehend. The genes in all living cells are composed of the same chemical, DNA. The DNA of all cells, whether from bacteria, plants, or animals including humans, is very similar. When DNA from a foreign species is transferred into a different cell, it functions exactly as the native DNA functions; that is, it "codes" for protein.
The easiest way to manipulate genes is using bacterial cells (most often Escherichia coli) and a vector, an agent that can be used to pass the gene from one cell to another. Plasmids, small extra circular DNA molecules found in many bacterial cells, are commonly used for this purpose. Plasmids are replicated along with the bacterial cell’s own DNA every time the cell reproduces. Plasmids can be easily isolated from bacterial cells. When a specific gene has been isolated, it can be fused, using restriction endonucleases, with a plasmid to produce a recombinant plasmid. These recombinant plasmids can then be put into bacterial cells by a process called transformation.
Martin Fernando - Biotechnology and Engineering
Biotechnology provides a means of developing higher-yielding crops in much less time than it takes to develop them though traditional plant-breeding programs. Genes for the desired characteristics can be inserted directly into the plant without having to go through repeated controlled selection and breeding cycles to establish the trait.
There are also economic advantages in diversifying agriculture production in a given area. A producer might wish to grow a particular high-value cash crop in an area where soil or climate conditions would prevent such a crop from thriving. Biotechnology can help solve these types of problems. For example, high value crops can be developed to grow in areas that heretofore would not have supported such crops. Plants also can be developed to produce new products such as antibiotics, drugs, hormones, and other pharmaceuticals.
Crop plants bioengineered to produce novel products mean that pharmaceuticals and other valuable products could be grown in farm environments rather than in laboratories. While there will be a growing pressure for agriculture to produce more food in the future, there will also be pressure for crop production to be more friendly to the environment. Biotechnology has the potential to play a major role in the development of a long-term, sustainable, environmentally friendly agricultural system. For example, the development of crop varieties with improved resistance to pests will reduce the reliance on pesticides.
Uma Maheshwar Rao - Biotechnology Revolution
Industrial biotechnology, also known as white biotechnology, is considered to be a revolutionary biotechnology field beside red and green biotechnology. After red (medicine) and green (agriculture), white biotechnology is now gaining momentum. With numerous applications e.g. in biocatalysis and fermentation technology, white biotech companies are able to produce – often from biomass out of agricultural products - bio-based chemicals (like vitamins, amino acids or enzymes for textile finishing and the detergent industry), biomaterials (like biodegradable plastics for packaging or medical applications) and biofuels. Biotechnological syntheses are supposed to revolutionize many classical chemical synthetic routes for established chemicals and will outpace those by higher cost-efficiency, saving feedstock and energy resources and offering valuable benefits to the environment by lower or even no greenhouse gas emissions.
Our global R & D network includes molecular biologist, biochemist , industial bacteriologist, immunoloist, microbiologist, bioprocess technologist.
The diversity of disciplines, experience, cultures and perspectives within HelixGene is strength. It is reinforced daily through the connections that link our technical employees with each other connections through which they can quickly tap the knowledge of colleagues around the world for insights into solving your technical challenges.
The success of our customers and of HelixGene is in part due to our R & D expertise. We are dedicated to hiring highly-qualified, committed people from a broad range of disciplines - and to nurturing their talent through continuing professional development. |
|
|
